Search
Patexia Research
Case number 1:18-cv-01005

Celgene Corporation v. Aurobindo Pharma Limited et al > Summary

Court Case Number 1:18-cv-01005

Filing Date Jul 6, 2018

Termination Date Oct 4, 2018

Court Delaware District Court

Status Dismissed - Voluntarily

JudgesRichard G. Andrews

Plaintiff

Celgene

Defendant

2

Aurobindo Pharma

Aurobindo Pharma USA

Cause

35:271 Patent Infringement

Related Patents

Doc No Title Issue date
09872854 Methods for the treatment of psoriatic arthritis using apremilast Jan 23, 2018
09018243 Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof Apr 28, 2015
08802717 Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione Aug 12, 2014
08455536 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione Jun 4, 2013
07893101 Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof Feb 22, 2011
07659302 Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione Feb 9, 2010
07427638 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereof Sep 23, 2008
07208516 Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione Apr 24, 2007
06962940 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof Nov 8, 2005
Menu